The expression of miR-34 is reduced in a variety of cancers as well as in cancer stem cells, suggesting that miR-Rx34 may have broad applicability as an anti-cancer agent in miRNA replacement strategies.
Tuesday, June 16, 2009
Presentation on miRNA replacement therapy
Mirna Therapeutics Presents Data at Keystone Symposium on MicroRNA and Cancer, Business Wire, June 15, 2009 [Entry in FriendFeed]. Excerpt:
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment